New study aims to map Real-World care for myelofibrosis patients with anemia

NCT ID NCT06976918

Recruiting now Knowledge-focused Sponsor: iOMEDICO AG Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study is following 200 people in Germany who have myelofibrosis (a type of bone marrow cancer) and anemia (low red blood cells). Researchers will track which treatments patients receive, how their disease responds, and how they feel over time. The goal is to gather real-world information to help doctors better understand treatment patterns and outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide doctors with clearer data on which treatments work best for myelofibrosis with anemia, improving care decisions.
What could go wrong: This is an observational study, not testing a new treatment. It collects data only, so it won't directly change or improve anyone's health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anemia myelofibrosis primary myelofibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANEMIA MYELOFIBROSIS MYELOFIBROSIS; ANEMIA POST POLYCYTHEMIA VERA MYELOFIBROSIS POST-ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS PRIMARY MYELOFIBROSIS SECONDARY MYELOFIBROSIS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Multiple sites all over Germany
RECRUITING

Multiple Locations, Germany

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.